Document Detail


Drug-eluting stents in a patient with favism: is the aspirin administration safe?
MedLine Citation:
PMID:  18852594     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We describe the case of a 64-year-old patient with glucose-6-phosphate dehydrogenase deficiency who was referred to our hospital because of an acute inferior myocardial infarction.Given the possible risk of acute haemolytic anaemia, aspirin was not given in the acute phase, and the patient was successfully treated by balloon angioplasty of the right coronary artery.After functional and genetic testing showing the presence of the Mediterranean mutation, known to be a class II variant, the patient received oral daily aspirin (100 mg) under strict monitoring in order to promptly detect any sign of haemolysis. After 4 days, a complex percutaneous coronary intervention with an implantation of two drug-eluting stents was successfully performed on the left coronary artery. After 3 months, the patient is free from adverse events.Glucose-6-phosphate dehydrogenase deficiency is commonly considered a contraindication to aspirin intake; however, this case shows that aspirin at low, antiplatelet dosage is well tolerated and should not be denied to patients with ischaemic heart disease and complex coronary anatomy.
Authors:
Stefano Rigattieri; Pasquale Silvestri; Angelo Minucci; Cristian Di Russo; Giuseppe Ferraiuolo; Bruno Giardina; Ettore Capoluongo; Paolo Loschiavo
Related Documents :
18474534 - Early glycoprotein iib-iiia inhibitors in primary angioplasty (egypt) cooperation: an i...
9739774 - Emergency management of acute myocardial infarction. focus on pharmacologic therapy.
10577464 - Newer antiplatelet agents in acute coronary syndromes.
12381234 - Pharmacological treatment of elderly patients with acute coronary syndromes without per...
850434 - Myocardial ischemia during cardiopulmonary bypass. the hazards of ventricular fibrillat...
12270854 - Contemporary percutaneous coronary intervention versus balloon angioplasty for multives...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of cardiovascular medicine (Hagerstown, Md.)     Volume:  9     ISSN:  1558-2027     ISO Abbreviation:  J Cardiovasc Med (Hagerstown)     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-10-14     Completed Date:  2009-01-09     Revised Date:  2009-05-28    
Medline Journal Info:
Nlm Unique ID:  101259752     Medline TA:  J Cardiovasc Med (Hagerstown)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1159-62     Citation Subset:  IM    
Affiliation:
U.O. Emodinamica e Cardiologia Interventistica, Italy. stefanorigattieri@yahoo.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Anemia, Hemolytic / chemically induced*,  genetics
Angioplasty, Transluminal, Percutaneous Coronary / adverse effects,  instrumentation*
Aspirin / administration & dosage,  adverse effects*
Coronary Angiography
Drug-Eluting Stents*
Favism / complications*,  enzymology,  genetics
Glucosephosphate Dehydrogenase / genetics
Humans
Male
Middle Aged
Mutation
Myocardial Infarction / complications,  drug therapy,  radiography,  therapy*
Platelet Aggregation Inhibitors / administration & dosage,  adverse effects*
Risk Assessment
Treatment Outcome
Chemical
Reg. No./Substance:
0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin; EC 1.1.1.49/Glucosephosphate Dehydrogenase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An uncommon case of right-sided throat pain and swallow syncope.
Next Document:  Myocardial ischemia due to a large coronary-pulmonary fistula with plexus-like morphology.